Clinical Trial Update: Non-Inferiority Comparison of Migrane® Versus Parcel ® For Treatment of Tensional Cephaleia [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Migrane® to Parcel® for tension-type headache was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tension-type Headache
• Tensional-type Headache

Drugs mentioned

• Migrane®
• Parcel®

Snippet

Sponsor: EMS | Conditions: Tensional-type Headache | Phase 3 | Status: WITHDRAWN